Primary Peritoneal Transitional Cell Carcinoma
NCI Definition: An extremely rare transitional cell carcinoma that arises from the peritoneum. 
There are 2 clinical trials for primary peritoneal transitional cell carcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain primary peritoneal transitional cell carcinoma as an inclusion criterion, 1 is phase 1 (1 open) and 1 is phase 1/phase 2 (1 open).
Nedisertib, oncolytic measles virus encoding thyroidal sodium iodide symporter, and pegylated liposomal doxorubicin are the most common interventions in primary peritoneal transitional cell carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.